262 related articles for article (PubMed ID: 16394280)
1. Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.
Mitterlechner T; Fiegl M; Mühlböck H; Oberaigner W; Dirnhofer S; Tzankov A
J Clin Pathol; 2006 Jan; 59(1):48-55. PubMed ID: 16394280
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
3. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
5. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
7. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
[TBL] [Abstract][Full Text] [Related]
8. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California.
Bracci PM; Holly EA
Cancer Causes Control; 2005 May; 16(4):333-46. PubMed ID: 15953976
[TBL] [Abstract][Full Text] [Related]
9. Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification.
Akhtar SS; Haque IU; Wafa SM; El-Saka H; Saroor AM; Nadrah HM
Saudi Med J; 2009 May; 30(5):677-81. PubMed ID: 19417969
[TBL] [Abstract][Full Text] [Related]
10. Parotid gland lymphoma: prognostic analysis of 2140 patients.
Feinstein AJ; Ciarleglio MM; Cong X; Otremba MD; Judson BL
Laryngoscope; 2013 May; 123(5):1199-203. PubMed ID: 23576299
[TBL] [Abstract][Full Text] [Related]
11. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
Broccia G; Cocco P; Casula P;
Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Economopoulos T; Papageorgiou S; Dimopoulos MA; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Acta Haematol; 2005; 113(2):97-103. PubMed ID: 15802887
[TBL] [Abstract][Full Text] [Related]
14. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
15. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of lymphoproliferative diseases in Northern Italy].
Milani M; Tricomi P; Zuccoli E; Rossi G; Pezzotta MG; Lari C; Cristofori E
Pathologica; 1996 Dec; 88(6):478-82. PubMed ID: 9206774
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphomas in Jos, Nigeria: a ten-year study.
Obafunwa JO; Akinsete I
Cent Afr J Med; 1992 Jan; 38(1):17-25. PubMed ID: 1633615
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the World Health Organization classification.
Yaqo RT; Hughson MD; Sulayvani FK; Al-Allawi NA
Indian J Cancer; 2011; 48(4):446-51. PubMed ID: 22293258
[TBL] [Abstract][Full Text] [Related]
19. Leukemia and lymphoma incidence in children in Alberta, Canada: a population-based 22-year retrospective study.
Kulkarni K; Stobart K; Witol A; Rosychuk RJ
Pediatr Hematol Oncol; 2011 Nov; 28(8):649-60. PubMed ID: 21981741
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
